Coleman I. Smith

Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy et al. · New England Journal of Medicine · 2002 · 6.4K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Kerry L. Donnelly, Coleman I. Smith, Sarah Jane Schwarzenberg et al. · Journal of Clinical Investigation · 2005 · 3.5K citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +17

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin

Peter Ferenci, Michael Fried, Mitchell L. Shiffman et al. · Journal of Hepatology · 2005 · 517 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C

K. Rajender Reddy, Teresa L. Wright, Paul J. Pockros et al. · Hepatology · 2001 · 360 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Kerry L. Donnelly, Coleman I. Smith, Sarah Jane Schwarzenberg et al. · Journal of Clinical Investigation · 2005 · 321 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +17